in December 2024 the FDA's Pharmacy Compounding Advisory Committee voted against adding it to the final 503A bulks list, citing nonclinical toxicity, an unresolved cardiac signal, and immunogenicity risk
Animal model studies demonstrate a biphasic response curve where low micromolar concentrations (110 M) produce maximal NF-B inhibition, while concentrations above 50 M show diminishing returns and, in some tissue types, paradoxical pro-inflammatory signaling
Amylin receptor activation requires far less compound than simultaneous triple receptor agonism
When the peptide binds to these receptors, it initiates a signaling cascade that increases the expression of lipolytic enzymes, particularly hormone-sensitive lipase, which breaks down stored triglycerides into free fatty acids and glycerol
Supplements are less expensive for routine use
For one thing, she says, the way a peptide is synthesized for research purposes (with a so-called TFA salt) is different and arguably makes it more toxic than an FDA-approved peptide formulated for human use